3. GRAIL $300,000,000
Round: Series C
Description: GRAIL develops a blood test to detect cancer early before symptoms appear offering higher survival rates compared to late-stage diagnosis.
Industry: Health Care, Health Diagnostics, Life Science, Medical Device
Location: Menlo Park, California
Date of funding: 05/21
Total equity funding: $1,611,655,039
Page 19 of 21
